Objective To systematically evaluate the efficacy and safety of Shufeng Jiedu Capsule（ 疏风解毒胶囊） combined with antibiotics in the treatment of community-acquired pneumonia. Methods The databases of CNKI

VIP and Wanfang

CBMdisc

Embase

PubMed

Cochrane Library

Sino Med were searched by computer

and randomized controlled trials of Shufeng Jiedu Capsule in treating CAP were collected. The search time ranged from building database to October 15

2017. Rev Man. 5. 3 software was used for meta-analysis of outcome indicators including cure rate

cough disappearance time

expectoration disappearance time

lung voice loss time

body temperature stabilization time

white blood cell count（ WBC）

C-reactive protein（ CRP）

procalcitonin（ PCT）

and the quality of evidence was assessed in accordance with the GRADE criteria. Results A total of 8 RCTs were included involving 874 patients. Meta-analysis showed that compared with antibiotics alone

Shufeng Jiedu Capsule combined with antibiotic treatment had more significant effect in cure rate

cough disappearance time

expectoration disappearance time

lung voice disappearance time

body temperature stability time

WBC

CRP（ P < 0. 05）; however

there was no significant difference in PCT between the two groups（ P > 0. 05）. According to the GRADE criteria

the two outcome indicators of cure rate and cough disappearance were medium-quality evidence

and lung voice disappearance time

WBC

and CRP were low-quality evidence. Conclusion The efficacy of Shufeng Jiedu Capsule combined with antibiotics in the treatment of CAP is better than that of antibiotics alone

but the methodological quality of the study is low.